Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Real-World Atopic Dermatitis: Italian Insights Grant
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Care of Persons Living with Metastatic Breast Cancer
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditions
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Inflammation & Immunology Canada
    Improving Advanced Prostate Cancer Management in Latin America
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico
    Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
    Release Date:
    Partner: The PROTEUS Consortium
    Review Process: Expert Review Panel
    Research Oncology USA
    Addressing Knowledge Gaps in Ulcerative Colitis (UC) Care
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2024 Inflammatory Bowel Disease (IBD) Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Closing the HRRm Testing Gap in Prostate Cancer Patients
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving the care and outcomes of residents of Canada living with metastatic NSCLC
    Release Date:
    Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving the Equity and Quality of Cancer Care in Colombia
    Release Date:
    Partner: The Colombian Association of Oncology and Hematology (ACHO)
    Review Process: Expert Review Panel
    Translation: Spanish (link)
    Quality Improvement Oncology Colombia
    Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
    Release Date:
    Partner: Crohn's & Colitis Foundation
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA